Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy

NCT ID: NCT01697943

Last Updated: 2012-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-31

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out more about differences of the quality of life in patients undergoing Roux-En-Y pouch reconstruction and conventional Roux-En-Y reconstruction. To find a better reconstruction for patients who received total gastrectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Total gastrectomy has been indicated mainly for advanced gastric cancer located from the upper to middle third of the stomach or multiple gastric cancers.The most common method of creating a way for food is called a "Roux-en-Y", in which one part of the intestines is connected with the end of the esophagus (the swallowing tube) in the abdomen, and another connection is made between the intestines ' lower down.

Patients with total gastrectomy suffer from poor food intake, anemia, and poor digestion because of loss of gastric reservoir or a lack of normal hormonal secretion for digestion. It often is associated with a limitation of postoperative quality of life (QOL). To improve postoperative nutritional status and QOL, surgeons have tried to establish ideal reconstruction after total gastrectomy and the optimum procedure for reconstruction has been discussed.

This study will compare the postoperative quality of life (QOL) of gastric pouch reconstruction with the usual reconstruction to see if the pouch makes patients feel better.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Tumor

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Gastric Malignant Tumor Total Gastrectomy Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Roux-En-Y Pouch Reconstruction or Roux-En-Y Reconstruction

Group Type EXPERIMENTAL

Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Pathologically confirmed gastric malignant tumor at fUSCC (biopsy may be performed at other institutions but slides must be confirmed at SHCA, as is routine care at our institution) , and the patients be assessed must be carried out total gastrectomy by three specialists.

* Patients 20-75 years old
* Normal organ function, able to tolerate surgery, no clear contraindication for surgery
* No evidence of metastases of adjacent organs
* be able to provide follow-up over 2 years
* No specific treatment for gastric cancer before surgery
* In line with the Declaration of Helsinki and the requirements of the hospital ethics committee.
* The subjects were able to understand and comply with the trial protocol, and signed informed consent.

Exclusion Criteria

* • Synchronous or metachronous (less than five years) and with other malignancies.

* Cirrhosis and portal hypertension
* Associated with blood diseases
* Serious heart/ lung and kidney dysfunction or with metabolic diseases such as diabetes, hyperthyroidism.
* Suffering from a serious neurological diseases or psychological diseases affecting the life
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fudan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yanong Wang

Director of Department of Abdominal Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ya Nong Wang, MD,PhD

Role: CONTACT

Phone: +86-21 64175590

Email: [email protected]

Hua Huang, MD,PhD

Role: CONTACT

Phone: +86-21 64175590

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ya Nong Wang, MD,PhD

Role: primary

Hua Huang, MD,PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-44-563

Identifier Type: -

Identifier Source: org_study_id